July 2011 | OncologyLive

Interim Safety Data Compared in Ixabepilone TITAN Trial

July 18, 2011

Researchers are continuing to explore whether ixabepilone (Ixempra) is a better choice as adjuvant chemotherapy for patients with early-stage, triple-negative breast cancer than the standard paclitaxel (Taxol).